Eagle Pharmaceuticals (EGRX) stock forecast for 2022 – 2027

Are you interested in Eagle Pharmaceuticals, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the EGRX stock price in 2022-2027. Is EGRX a good long term stock? When should I take profit in Eagle Pharmaceuticals stock? Buy or sell stock? Will EGRX stock price go up? What are analysts’ forecasts for EGRX stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. EGRX stock returns are also predicted based on historical data.

According to our research, EGRX stock is a bad long-term investment. EGRX share price has been in a bear cycle for the past year. Eagle Pharmaceuticals, Inc. stock trend is negative.

Eagle Pharmaceuticals company info

Industry Drug Manufacturers—Specialty & Generic
Address 50 Tice Boulevard, Woodcliff Lake, NJ, 07677, United States
Website https://www.eagleus.com

Forecasting

52 Week High: 51.8763 USD
52 Week Low: 40.4613 USD
1 Year Forecast: 40.0526 USD
5 Year Forecast: 0 USD

Agilent Technologies info

Market Cap: 595.07M
52 Week Change: -3.824%
52 Week High: 58.25 USD
52 Week Low: 36.48 USD
Beta: 0.691518
50 Day Moving Average: 50.06
90 Day Moving Average: 49.814
200 Day Moving Average: 50.52
Resistance Level: 47.776
Pivot Point: 46.2449
Support Level: 44.8672
Enterprise Value: 597,318,016
Forward P/E: 6.16
Forward EPS: 7.37
Profit Margin: 3.14%
Shares Outstanding: 12,913,900
EBITDA: 77.18
Held Percent Institutions: 94.55%
PEG Ratio (5Y): 7.42
Trailing EPS: 0.43

Eagle Pharmaceuticals stock forecasts for 2022-2027

DateOpen PriceClose PriceChange

Eagle Pharmaceuticals Stock Forecast for 2022

March 2022 48 44.88 -6.5%
April 2022 44.88 47 4.72%
May 2022 46.53 48.96 5.22%
June 2022 49.49 49.98 0.99%
July 2022 49.98 49.5 -0.96%
August 2022 49.98 47.52 -4.92%
September 2022 48.48 48.96 0.99%
October 2022 47.52 45 -5.3%
November 2022 44.55 45.08 1.19%
December 2022 45.54 46.92 3.03%

Eagle Pharmaceuticals Stock Forecast for 2023

January 2023 45.54 40.59 -10.87%
February 2023 40.4 44.88 11.09%
March 2023 44.44 40 -9.99%
April 2023 40 41.16 2.9%
May 2023 43 44.88 4.37%
June 2023 44 45.54 3.5%
July 2023 46.92 45 -4.09%
August 2023 44.1 42.14 -4.44%
September 2023 42.14 42.14 0%
October 2023 43.43 39.6 -8.82%
November 2023 40.4 42.42 5%
December 2023 42 41.41 -1.4%

Eagle Pharmaceuticals Stock Forecast for 2024

January 2024 41.41 35.28 -14.8%
February 2024 35.28 39.78 12.76%
March 2024 38.61 34.65 -10.26%
April 2024 34.65 37.62 8.57%
May 2024 37.24 38.61 3.68%
June 2024 38.61 41.82 8.31%
July 2024 42 39.2 -6.67%
August 2024 40.4 38 -5.94%
September 2024 38.76 39.39 1.63%
October 2024 39 36.36 -6.77%
November 2024 35.28 37.74 6.97%
December 2024 36.26 37.74 4.08%

Eagle Pharmaceuticals Stock Forecast for 2025

January 2025 37 31 -16.22%
February 2025 30.69 33.66 9.68%
March 2025 33.32 30.6 -8.16%
April 2025 29.4 33 12.24%
May 2025 33.66 33.32 -1.01%
June 2025 33.66 36.63 8.82%
July 2025 37.74 36.72 -2.7%
August 2025 35.7 33.66 -5.71%
September 2025 32.34 34.68 7.24%
October 2025 34.34 31.31 -8.82%
November 2025 31 32 3.23%
December 2025 31.68 31.68 0%

Eagle Pharmaceuticals Stock Forecast for 2026

January 2026 31.68 27 -14.77%
February 2026 25.74 29 12.67%
March 2026 29 25.74 -11.24%
April 2026 26.26 29.58 12.64%
May 2026 28.42 30.3 6.62%
June 2026 29.4 31.68 7.76%
July 2026 32.32 30.38 -6%
August 2026 30.3 28.71 -5.25%
September 2026 28.42 28.71 1.02%
October 2026 28.71 25.74 -10.34%
November 2026 26.52 28.28 6.64%
December 2026 28.28 27.27 -3.57%

Eagle Pharmaceuticals Stock Forecast for 2027

January 2027 27 22.22 -17.7%